ID   NeuCHO
AC   CVCL_IR07
SY   NeuCho
DR   Wikidata; Q54930417
RX   Patent=US20170233695;
WW   Provider; NeuClone; -; http://www.neuclone.com/technology/
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, Cell Bank Australia; CBA20130024.
CC   Selected for resistance to: ChEBI; CHEBI_44185; Methotrexate (MTX).
CC   Sequence variation: Gene deletion; UniProtKB; Q2MH30; Dhfr; Zygosity=Homozygous (from parent cell line).
CC   Genetic integration: Method=Transfection; Gene=HGNC; HGNC:4261; GH1.
CC   Transformant: NCIt; C129640; Cobalt-60 gamma radiation.
CC   Derived from site: In situ; Ovary; UBERON=UBERON_0000992.
CC   Cell type: Epithelial cell of ovary; CL=CL_2000064.
OX   NCBI_TaxID=10029; ! Cricetulus griseus (Chinese hamster)
HI   CVCL_7180 ! CHO-DG44
SX   Female
AG   Adult
CA   Transformed cell line
DT   Created: 03-03-17; Last updated: 10-04-25; Version: 13
//
RX   Patent=US20170233695;
RA   Sunstrom N.-A.;
RT   "Cell culture media composition and methods of producing thereof.";
RL   Patent number US20170233695, 17-Aug-2017.
//